Cassava Sciences, Inc.
Key Metrics
Market Snapshot
About
Cassava Sciences, Inc. is a clinical-stage biotechnology company focused on developing treatments for Alzheimer's disease. The company is advancing its lead product candidate simufilam, an oral therapy designed to restore neuronal function in Alzheimer's patients. Cassava Sciences aims to address the underlying pathology of the disease through its proprietary approach to neurodegeneration.